Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico


Por: Taboada, Blanca, Vazquez-Perez, Joel Armando, Munoz-Medina, Jose Esteban, Ramos-Cervantes, Pilar, Escalera-Zamudio, Marina, Boukadida, Celia, Sanchez-Flores, Alejandro, ISA, PAVEL, Mendieta-Condado, Edgar, Martinez-Orozco, Jose A., Becerril-Vargas, Eduardo, Salas-Hernandez, Jorge, Grande, Ricardo, Gonzalez-Torres, Carolina, Gaytan-Cervantes, Francisco Javier, Vazquez, Gloria, Pulido, Francisco, Araiza-Rodriguez, Adnan, Garces-Ayala, Fabiola, Gonzalez-Bonilla, Cesar Raul, Grajales-Muniz, Concepcion, Borja-Aburto, Victor Hugo, Barrera-Badillo, Gisela, LOPEZ, SUSANA, Hernandez-Rivas, Lucia, Perez-Padilla, Rogelio, Lopez-Martinez, Irma, avila-Rios, Santiago, Ruiz-Palacios, Guillermo, Ramirez-Gonzalez, Jose Ernesto, Arias, Carlos F.

Publicada: 1 sep 2020
Resumen:
The coronavirus disease 2019 (COVID-19) pandemic has affected most countries in the world. Studying the evolution and transmission patterns in different countries is crucial to enabling implementation of effective strategies for disease control and prevention. In this work, we present the full genome sequence for 17 SARS-CoV-2 isolates corresponding to the earliest sampled cases in Mexico. Global and local phylogenomics, coupled with mutational analysis, consistently revealed that these viral sequences are distributed within 2 known lineages, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage A/G, containing mostly sequences from North America, and lineage B/S, containing mainly sequences from Europe. Based on the exposure history of the cases and on the phylogenomic analysis, we characterized 14 independent introduction events. Additionally, three cases with no travel history were identified. We found evidence that two of these cases represented local transmission cases occurring in Mexico during mid-March 2020, denoting the earliest events described for the country. Within this local transmission cluster, we also identified an H49Y amino acid change in the Spike protein. This mutation represents a homoplasy occurring independently through time and space and may function as a molecular marker to follow any further spread of these viral variants throughout the country. Our results provide a general picture of the SARS-CoV-2 variants introduced at the beginning of the outbreak in Mexico, setting the foundation for future surveillance efforts. IMPORTANCE Understanding the introduction, spread, and establishment of SARS-CoV-2 within distinct human populations as well as the evolution of the pandemics is crucial to implement effective control strategies. In this work, we report that the initial virus strains introduced in Mexico came from Europe and the United States and that the virus was circulating locally in the country as early as mid-March. We also found evidence for early local transmission of strains with a H49Y mutation in the Spike protein, which could be further used as a molecular marker to follow viral spread within the country and the region.

Filiaciones:
Taboada, Blanca:
 Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca, Morelos, Mexico

Vazquez-Perez, Joel Armando:
 Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Mexico City, DF, Mexico

Munoz-Medina, Jose Esteban:
 Inst Mexicano Seguro Social, Div Labs Vigilancia & Invest Epidemiol, Mexico City, DF, Mexico

Ramos-Cervantes, Pilar:
 Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico

Escalera-Zamudio, Marina:
 Univ Oxford, Dept Zool, Oxford, England

Boukadida, Celia:
 Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Ctr Invest Enfermedades Infecciosas, Mexico City, DF, Mexico

Sanchez-Flores, Alejandro:
 Univ Nacl Autonoma Mexico, Unidad Univ Secuenciac Masiva & Bioinformat, Inst Biotecnol, Cuernavaca, Morelos, Mexico

ISA, PAVEL:
 Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca, Morelos, Mexico

Mendieta-Condado, Edgar:
 Inst Diagnost & Referencia Epidemiol, Direcc Gen Epidemiol, Mexico City, DF, Mexico

Martinez-Orozco, Jose A.:
 Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Mexico City, DF, Mexico

Becerril-Vargas, Eduardo:
 Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Mexico City, DF, Mexico

Salas-Hernandez, Jorge:
 Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Mexico City, DF, Mexico

Grande, Ricardo:
 Univ Nacl Autonoma Mexico, Unidad Univ Secuenciac Masiva & Bioinformat, Inst Biotecnol, Cuernavaca, Morelos, Mexico

Gonzalez-Torres, Carolina:
 Inst Mexicano Seguro Social, Div Desarrollo Invest, Mexico City, DF, Mexico

Gaytan-Cervantes, Francisco Javier:
 Inst Mexicano Seguro Social, Div Desarrollo Invest, Mexico City, DF, Mexico

Vazquez, Gloria:
 Univ Nacl Autonoma Mexico, Unidad Univ Secuenciac Masiva & Bioinformat, Inst Biotecnol, Cuernavaca, Morelos, Mexico

Pulido, Francisco:
 Univ Nacl Autonoma Mexico, Unidad Univ Secuenciac Masiva & Bioinformat, Inst Biotecnol, Cuernavaca, Morelos, Mexico

Araiza-Rodriguez, Adnan:
 Inst Diagnost & Referencia Epidemiol, Direcc Gen Epidemiol, Mexico City, DF, Mexico

Garces-Ayala, Fabiola:
 Inst Diagnost & Referencia Epidemiol, Direcc Gen Epidemiol, Mexico City, DF, Mexico

Gonzalez-Bonilla, Cesar Raul:
 Inst Mexicano Seguro Social, Coordinac Invest Salud, Mexico City, DF, Mexico

Grajales-Muniz, Concepcion:
 Inst Mexicano Seguro Social, Coordinac Control Tecn Insumos, Mexico City, DF, Mexico

Borja-Aburto, Victor Hugo:
 Inst Mexicano Seguro Social, Direcc Prestac Med, Mexico City, DF, Mexico

Barrera-Badillo, Gisela:
 Inst Diagnost & Referencia Epidemiol, Direcc Gen Epidemiol, Mexico City, DF, Mexico

LOPEZ, SUSANA:
 Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca, Morelos, Mexico

Hernandez-Rivas, Lucia:
 Inst Diagnost & Referencia Epidemiol, Direcc Gen Epidemiol, Mexico City, DF, Mexico

Perez-Padilla, Rogelio:
 Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Mexico City, DF, Mexico

Lopez-Martinez, Irma:
 Inst Diagnost & Referencia Epidemiol, Direcc Gen Epidemiol, Mexico City, DF, Mexico

avila-Rios, Santiago:
 Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Ctr Invest Enfermedades Infecciosas, Mexico City, DF, Mexico

Ruiz-Palacios, Guillermo:
 Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico

Ramirez-Gonzalez, Jose Ernesto:
 Inst Diagnost & Referencia Epidemiol, Direcc Gen Epidemiol, Mexico City, DF, Mexico

Arias, Carlos F.:
 Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca, Morelos, Mexico
ISSN: 0022538X
Editorial
American Society for Microbiology, 1752 N ST NW, WASHINGTON, DC 20036-2904 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 94 Número: 18
Páginas:
WOS Id: 000568836000008
ID de PubMed: 32641486

MÉTRICAS